• Explore /
  • Poster
  • / Phase II (window) preoperative study of olaparib with cisplatin or with durvalumab or alone or no treatment in patients with histologically proven head and neck squamous cell carcinoma who are candidates for surgery (OPHELIA).

Phase II (window) preoperative study of olaparib with cisplatin or with durvalumab or alone or no treatment in patients with histologically proven head and neck squamous cell carcinoma who are candidates for surgery (OPHELIA).

Abstract Poster

Authors

Amanda Psyrri

Amanda Psyrri

University General Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece

Amanda Psyrri , George Papaxoinis , Panagiota Economopoulou , Ioannis Kotsantis , Vassiliki Kotoula , Onoufrios Tsavaris , Chrysanthi Avgerinou , George Fountzilas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT02882308

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS6096)

DOI

10.1200/JCO.2017.35.15_suppl.TPS6096

Abstract #

TPS6096

Poster Bd #

81a

Abstract Disclosures

Similar Posters

First Author: Amanda Psyrri

First Author: Amanda Psyrri

First Author: Enrique Grande

First Author: Juan Francisco Rodriguez-Moreno